Applied Biomics, Inc. is a Proteomics Service company established in 2005. We are centrally located in the San Francisco Bay Area, and occupy over 5,000 sq ft of lab and office spaces. We are dedicated to providing top-quality, cost-effective and full-line proteomics services to meet our customers’ research and discovery needs.

We cover both major platforms of proteomics: Gel-based 2D DIGE (2-dimensional differential in-gel electrophoresis) and Liquid-based iTRAQ® (isobaric tags for relative and absolute quantitation). Our proteomics services start from customized experimental design, sample preparations, protein separations/quantifications, protein identifications to publication-ready data. Our proprietary sample preparation procedures have been optimized for every specific sample types. The 2D DIGE / iTRAQ® are powerful platforms for quantitating changes in global protein expressions in various research applications.

Why choose us:

  • High quality: Over 400 peer-reviewed publications have cited our services
  • Quick turnaround: One-week on most services
  • Cost effective: Price covers from sample preparation to publication-ready data
  • Complimentary experimental design: Each project is catered to achieve its specific goal
  • Proprietary sample preparation
  • Excellent support: All project leaders are PhD scientists who perform the experiments and communicate with customers directly
  • All in-house services: All listed services are performed in-house
  • Extensive experience in working with academic, government and industrial customers

Thousands of scientists from academic, industrial and clinical laboratories have used our services to facilitate their researches in the following fields:

  • Determining HCP antibody coverage and detecting HCP contaminants
  • Improving product purification process
  • Identifying therapeutic or diagnostic markers in different diseases
  • Identifying antigens or auto-antigens from tissues and cells
  • Identifying key regulators in major biological pathways
  • Studying post-translational modifications such as phosphorylation, glycosylation and others
  • Validating drug targets